Any diagnosis of cancer is frightening, but the functional, psychological and cosmetic effects of oral cancer treatment create an additional layer of fear. Even patients who are treated successfully will require care throughout their lives. This disease exacts an unending physical and mental price.
CURE spoke with Yvonee Saenger about the future use of Opdivo and Yervoy in melanoma.
The FDA granted Keytruda a priority review for the first-line treatment of some patients with NSCLC.
What does it feel like when a friend with metastatic cancer learns that cancer has spread again?
Breast cancer and melanoma survivor works on resilience to cope with her two cancers.
A recent study showed that patients with MPNs treated with Jakafi off a clinical trial still benefited from the drug.
The chemotherapy agent capecitabine causes some patients to lose their fingerprints.
After multiple bouts with cancer, Taylor Hendrix was inspired to become an oncology nurse.
This male breast cancer survivor spent a year in residence in a Zen Buddhist Temple. Then he got cancer. Here’s what he learned.
When a cancer diagnosis requires a lifestyle overhaul, it's important to recognize the gifts this forced transition brings.
A recent review showed that music therapy helped ease symptoms in patients who were undergoing treatment for cancer.
A three-drug approach is proving beneficial for the treatment of multiple myeloma.
Several factors cause women a delay in getting surgery to treat endometrial cancer.
On starting a new chapter, but never forgetting.
I’m not sure that’s the right term. Do I have a choice?
According to recent findings from a phase 3 trial, the immunotherapy Tecentriq (atezolizumab) improved survival compared with docetaxel in patients with advanced non–small cell lung cancer (NSCLC) following the failure of platinum-based chemotherapy.
Approximately 46 percent of patients with breast cancer at high risk for recurrence but low genomic risk according to the 70-gene breast cancer recurrence assay (MammaPrint) might not require adjuvant chemotherapy.
Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for Hispanic men, rates have remained essentially unchanged. A new study suggests that lower rates of screening may be the driver of this disparity.
Learning to navigate breast cancer is easier with someone by your side.
Banding together with my large family had a positive effect not only on my brother, a patient, but on all of us.
The FDA has approved Blincyto (blinatumomab) for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Women who are unable to travel to genetic counselors may be able to reap the same benefits over the phone, according to a recent study.
This dynamic suggests an important area of focus for oncologists and other health care professionals who provide care for the nation’s growing population of cancer survivors.
One of the methods my wife and I developed to ward of the cynicism that comes when faced with such an unrelenting foe is something we call "playing the cancer card."
Two-time cancer survivor suspects survivors look at the material stuff or clutter of life differently since their cancer diagnosis.
Pacritinib decreased spleen size, but did not improve total symptom scores in a group of patients with myelofibrosis.
Arzerra was approved in combination with fludarabine and cyclophosphamide to treat patients with CLL.
What happens when chemotherapy ends?
While it is obvious that we will think of cancer, it is how we do so that matters.
